Cummings JJ, D'Eugenio DB, Gross SJA controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med.1989;320:1505-1510.
2.
Collaborative Dexamethasone Trial Group.Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial. Pediatrics.1991;88:421-427.
3.
Fauci ASDifferential effects of in vivo hydrocortisone, prednisone and dexamethasone on in vitro expression of lymphocyte function. Clin Exp Immunol . 1976;24:54-62.
4.
Cunningham DS , Evans EEThe effects of betamethasone on maternal cellular resistance to infection. Am J Obstet GynecoL1991;165:610-615.
5.
Lammie PJ, Leiva LE, Ruff AJ, et al. Bancroftian filariasis in Haiti: preliminary characterization of the immunological responsiveness of microfilaremic individuals. Am J Trop Med Hyg.1983;38:125-129.
6.
Pittard WB III, Miller K., Sorensen RUNormal lymphocyte responses to mitogens in term and preterm neonates following normal and abnormal intrauterine growth. Clin Immunol Immunopathol.1984;30:178-187.
7.
Wilson CBImmunologic basis for increased susceptibility of the neonate to infection . J Pediatr.1986;108:1-12.
8.
Ryhänen P., Kauppila A., Koivisto M.Unaltered neonatal cell-mediated immunity after prenatal dexamethasone treatment . Obstet Gynecol.1980;56:182-185.
9.
Dale DC, Fauci AS, Guerry IV D., Wolff SMComparison of agents producing a neutrophilic leukocytosis in man. J Clin Invest.1975;56:808-813.
10.
Xanthou M.Leucocyte blood picture in healthy full-term and premature babies during neonatal period. Arch Dis Child.1970;45:242-249.
